EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link: https://ebookbell.com/faq

We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.

For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Mammalian Trp Channels As Molecular Targets Novartis Foundn Symp Derek J Chadwick

Name: Mammalian Trp Channels As Molecular Targets Novartis Foundn Symp Derek J Chadwick
SKU: BELL-4092218
Price: 31.00 USD
Availability: InStock
Rating: 5 (20 reviews)

SKU: BELL-4092218

$ 31.00 ~~$ 45.00~~ (-31%)

5.0

20 reviews

Mammalian Trp Channels As Molecular Targets Novartis Foundn Symp Derek J Chadwick instant download after payment.

Publisher: Wiley

File Extension: PDF

File size: 3.22 MB

Pages: 286

Author: Derek J. Chadwick, Jamie A. Goode

ISBN: 9780470862544, 0470862548

Language: English

Year: 2004

Product desciption

Mammalian Trp Channels As Molecular Targets Novartis Foundn Symp Derek J Chadwick by Derek J. Chadwick, Jamie A. Goode 9780470862544, 0470862548 instant download after payment.

This book brings together contributions from key investigators in the area of Transient Receptor Potential (TRP) channel structure and function. It covers the structure, function and regulation of mammalian TRP channels and mechanisms of signal transduction. The discussions indicate research that would improve understanding of the role of TRP channels in normal cellular physiology, the involvement of TRP channels in disease states and their potential use as molecular targets for novel therapeutic agents